I strongly believe that age is just a number.There was a point in my cancer journey when I bargained with God. I asked him why he allowed me to get diagnosed in my twenties and wished he could have changed the timing to at least my forties or fifties.

What’s the most favorite thing about yourself? My answer used to be my thick hair. It was organically long, healthy, and shiny. I used to follow the Asian stereotype where nothing about my body was #thiccccc, except my hair.

In this engaging webinar, Clara, Heather, and Dan lead a discussion on the exciting ways stakeholders are optimizing registries to enhance research insights. The session explores the concept of the "Reimagined Registry" and delves into the characteristics of traditional registries. Patient registries are introduced as organized systems utilizing observational study methods to collect standardized patient information. These registries play a pivotal role in providing valuable real-world data for diverse research needs and inquiries. Join us in uncovering the potential of reimagined registries for research excellence.

Why You're Never 'Done' Even After Breast Cancer Treatment

Why You're Never 'Done' Even After Breast Cancer Treatment

Get to know Sara Snell Taylor, Senior Epidemiologist at PicnicHealth and discover how she leverages real-world data to improve patient outcomes

PicnicHealth is thrilled to announce our entry into the real-world data market for oncology. Leveraging our successes in chronic and rare diseases, we're now dedicated to advancing oncology research by collaborating directly with people living with cancer.

Roche has selected PicnicHealth as its partner to study Alzhemier’s disease (AD) in real world patients through their latest project, EMPOWER AD. The partnership leverages PicnicHealth’s end-to-end patient-centric approach to building registries from recruitment, to medical records retrieval, and machine learning (ML)-driven, human-curated data abstraction.

Welcome to PicnicHealth’s Team Spotlight series, where we introduce you to the talented people that are working behind the scenes at PicnicHealth. Today you’ll get to know Justin Maslin, the Engineering Manager for the Care Experience team at PicnicHealth

In the era of telehealth and increased inclusivity, the FDA's recommendations pave the way for more patient-centric trials held at non-traditional locations. This game-changing guidance provides invaluable insights into DCT design, remote trial visits, electronic informed consent, safety monitoring, and leveraging digital health technologies.

The global health economics and outcomes research (HEOR) market continues to grow year over year and is estimated to reach 2.46 billion by 2026. Read on for a breakdown of the top 5 trends driving this exciting industry growth.

Patients typically access their medical records through patient portals, which are online platforms that allow you to view their health information and communicate with your healthcare providers. Many patient portals are part of an electronic health record (EHR) system used by healthcare providers. While EHR systems are helpful tools for managing records from one facility, requesting prescription refills, or paying bills, they often fall short when consolidating information from different healthcare organizations or participating in research.

Clinical trials and PicnicHealth are two approaches when it comes to advancing medical knowledge and improving patient outcomes. While both clinical trials and PicnicHealth have their strengths and limitations, it's important to understand the differences between the two when considering options for improving healthcare.

Whether or not you had the opportunity to attend the three action-packed days of ISPOR this year, we’ve got you covered with a summary of 4 major themes that emerged.

Managing an IgA nephropathy (IgAN) diagnosis, whether it's yours or that of a loved one, can feel incredibly overwhelming, isolating, and just plain difficult. These five content creators living with IgAN are giving hope to the community by sharing their real experiences, tips, and resources to remind you you’re not alone.

With increasing applications of real-world data (RWD) upstream in the drug development lifecycle, it’s critical to recognize that there is no one-size-fits-all approach. So how can one incorporate different types of data from patients into clinical trials? Through conversation with a panel of experts from the biopharma industry and health technology companies, we will discuss scenarios when patient-mediated, tokenized and/or site-based approaches are warranted. Gaelan Ritter, Sneha Kishnani, and Andrew Larsen share their unique perspectives on the importance of a tailored yet flexible strategy and the potential value this can unlock for researchers and patients alike.Watch the recorded webinar or read the transcript below to explore design considerations for incorporating different types of real-world data into clinical trials.

Although there is a large and diversified group of Asian Americans and Pacific Islanders (AAPI) in the United States, clinical trials and medical research frequently underrepresent this group. This underrepresentation result in a lack of knowledge about how particular medications and therapies affect AAPI people, potentially resulting in less effective or even hazardous medical interventions.

PicnicHealth is excited to announce that we are expanding our long-term partnership with Roche and Genentech to better understand brain health and accelerate neurological disease research using real-world data.

Sarah You is an IgAN Change Champion who has used her challenges with IgA nephropathy to help others. Sarah was diagnosed with IgAN when she was 21 years old, living as an international student in the US. She flew back to receive treatment and be with her family in Korea following her diagnosis. Now that she understands how to manage her IgAN, she has a master's degree in immunology and is currently applying to medical schools so she can be a support system for other rare disease patients.

This year, the FDA shed light on important, cross-cutting considerations for patient-level, real-world data to serve as an external control arm. Our new blog post highlights what you need to know - and the data you need to have - to conduct an externally controlled trial.

IgA nephropathy (IgAN) is a type of kidney disease that affects the glomeruli, the tiny filtering units within the kidneys. To diagnose and monitor IgAN, patients typically undergo a range of tests, including blood labs for kidney diseases, urine tests for kidney disease, and imaging studies.

CureDuchenne and PicnicHealth Announce Real-World Evidence-Focused Partnership to Incorporate Participant Medical Records into CureDuchenne Link

In the US, nearly two million kidney biopsies are performed each year at a rate of 175 procedures per million population. Kidney biopsies can reveal important information about kidney function and inform nephrologists about the possible cause of symptoms that brought the patient in for a visit in the first place.

Managing a chronic condition can be challenging, but there are tools to help patients monitor their health and manage their symptoms. From wearable health monitors to online medical record platforms, blood pressure monitors, symptom-tracking apps, and diet-tracking tools, patients have a variety of resources at their disposal. Here are six tools that can help you take control of your health and manage your IgA Nephropathy:

There are many organizations dedicated to helping patients with IgA nephropathy. Here are five of the top organizations that IgA nephropathy patients can turn to for support and resources.